title: Hyperoxic reperfusion exacerbates postischemic renal dysfunction.
abstract: BACKGROUND
  Hyperoxic reperfusion from global ischemia worsens functional outcome because of oxygen radical-mediated injury. This study tested the hypothesis that hyperoxic reperfusion would exacerbate postischemic renal dysfunction.
  
  
  METHODS
  Twenty-nine healthy, uninephrectomized, male mongrel rabbits (Oryctolagus cuniculus) in 3 groups were subjected to 30 minutes of complete normothermic renal ischemia followed by reperfusion under hyperoxic or normoxic conditions. The groups were: hyperoxically reperfused (n = 8), normoxically reperfused (n = 8), hyperoxic sham (no ischemia, n = 5), and allopurinol-pretreated (50 mg/kg, intravenously), hyperoxically reperfused animals (n = 8). Plasma concentrations of creatinine, urea nitrogen and electrolytes were measured at 0, 24, 48, and 72 hours after ischemia and served as functional outcome markers. Histopathologic analysis of kidneys for injury was performed by an expert who was blinded to the procedures.
  
  
  RESULTS
  Plasma creatinine in hyperoxically reperfused rabbits was significantly elevated above normoxic (P =.02) and sham (P =.003) animals by 48 hours and remained elevated to 72 hours. Plasma urea nitrogen in hyperoxically reperfused rabbits was significantly elevated above the normoxic group (P = .01), the sham group (P = .02), and the allopurinol group (P = .04) by 72 hours. These coincided with a significantly elevated histopathologic injury score in hyperoxically reperfused rabbits compared with sham (P = .019), normoxic (P = .035), and allopurinol-pretreated hyperoxically reperfused animals (P = .037).
  
  
  CONCLUSIONS
  Hyperoxic reperfusion exacerbates renal dysfunction after 30 minutes of complete normothermic ischemia. This dysfunction may be mediated by oxygen radical-related injury.
authors.affiliation: Department of Biology, Dickinson College, Carlisle, PA, USA.
authors.forename: C F
authors.initials: CF
authors.lastname: Zwemer
authors.forename: J L
authors.initials: JL
authors.lastname: Shoemaker
authors.forename: S W
authors.initials: SW
authors.lastname: Hazard
authors.forename: R E
authors.initials: RE
authors.lastname: Davis
authors.forename: A G
authors.initials: AG
authors.lastname: Bartoletti
authors.forename: C L
authors.initials: CL
authors.lastname: Phillips
mesh_terms: D000493:Allopurinol / Q000494:pharmacology; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000097:blood; D018496:Hyperoxia / Q000473:pathology / Q000503:physiopathology*; D007511:Ischemia / Q000473:pathology / Q000503:physiopathology*; D007668:Kidney / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D011817:Rabbits; D012016:Reference Values; D012079:Renal Circulation; D015427:Reperfusion Injury / Q000473:pathology / Q000503:physiopathology*
chemical_list: D000975:Antioxidants; D000493:Allopurinol; D003404:Creatinine